TATVA

Tatva Chintan Pharma Chem LimitedNSELive
₹1,690+261.90 (+18.34%)

Market Open · NSE · INR

Open

₹1,525

High

₹1,713.7

Low

₹1,520

Prev Close

₹1,428.1

52-Week Range100% from low
₹928.05
₹1,690

Market Cap

₹3340.62 Cr

Small Cap

P/E (TTM)

65

EPS

₹21.97

Div Yield

0.07%

P/B Ratio

5.36

ROE

6.6%

Key Metrics

Forward P/E36.23
Book Value₹315.1
Debt/Equity0.15×
Revenue Growth43.0%
Profit Margin9.57%
Operating Margin17.33%
Volume1.27 L
Avg Volume (20d)56.8 K
Delivery %45.00%
Trades13,100

Analyst Ratings(3 analysts)

Hold

Target Price

₹1,390

-17.8% upside

Buy1
Sell1
Strong Sell1
Low: ₹835Median: ₹1,380High: ₹1,955

Current price: ₹1,690

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

Basic MaterialsSpecialty Chemicals

Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor bat...

tatvachintan.com679 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 1.00/share
22
23
24
25
12 Sept 20251.00
06 Sept 20242.00
08 Sept 20232.00
08 Sept 20222.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.